National Health Determination under paragraph 98C(1)(b) Amendment 2014 (No. 3) (No. PB 19 of 2014)

Link to law: https://www.comlaw.gov.au/Details/F2014L00357

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
PB 19 of 2014
 
National Health Determination under paragraph 98C(1)(b) Amendment 2014
(No. 3)
_____________________________________________________________________
 
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated 21 March 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
1              Name of Instrument
(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2014 (No. 3).
(2)                This Instrument may also be cited as PB 19 of 2014.
2              Commencement                                                        
                This instrument commences on 1 April 2014.
3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]        Schedule 3, entry for Morphine
omit:
 
Injection containing morphine sulphate 10 mg in 1 mL (with preservative)
[2]        Schedule 3, entry for Oxycodone
omit:
 
Tablet containing oxycodone hydrochloride 5 mg (controlled release)
[3]        Schedule 4, after entry for Calcipotriol with betamethasone in the form Gel containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g
insert in the column headed “Form (strength, type, size, etc.)”:
 
Gel containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g
[4]        Schedule 4, after entry for Clarithromycin
insert:
Clobetasol
Shampoo containing clobetasol propionate 500 micrograms per mL,
125 mL